Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25) (N-Term) Peptide
-
- Target See all DR3/LARD (TNFRSF25) products
- DR3/LARD (TNFRSF25) (Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
16 amino amino terminus of human DR3.
Human
-
-
- Application Notes
- DR3 peptide is used for blocking the activity of DR3.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- DR3/LARD (TNFRSF25) (Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
- Synonyms
- APO-3 Peptide, DDR3 Peptide, DR3 Peptide, LARD Peptide, TNFRSF12 Peptide, TR3 Peptide, TRAMP Peptide, WSL-1 Peptide, WSL-LR Peptide, Tnfrsf12 Peptide, Wsl Peptide, TNFRSF25 Peptide, TNF receptor superfamily member 25 Peptide, tumor necrosis factor receptor superfamily, member 25 Peptide, TNFRSF25 Peptide, Tnfrsf25 Peptide
-